Jing H, Ding Y, Li Z
Nanjing General Hospital of People's Liberation Army.
Zhonghua Wai Ke Za Zhi. 1995 Sep;33(9):559-60.
In July 1994, we performed orthotopic heart transplantation for a patient with hypertrophic myocardiopathy, who had had open heart surgery enlarging the right ventricular outlet. The patient had an excellent postoperative result. He received triple-drug immunosuppressive therapy. Large dose of methyl-prednisolone was used successfully for his acute rejection reaction. At present, the patient is living well with good cardiac, hepatic and renal function. We described donor heart harvest, myocardial protection, operative procedure, immune monitoring, anti-rejection and anti-infectious therapy. We introduced the process of protecting donor heart on the way to hospital by retrograde perfusion with medium hypothermic oxygenated-blood combined with St. Thomas cardioplegia. Besides endomyocardial biopsy, other noninvasive examinations such as noninvasive cardiac output monitoring could be helpful to monitor acute rejection reaction.
1994年7月,我们为一名肥厚型心肌病患者进行了原位心脏移植,该患者曾接受过扩大右心室出口的心脏直视手术。患者术后效果极佳。他接受了三联药物免疫抑制治疗。大剂量甲基强的松龙成功用于治疗他的急性排斥反应。目前,患者心脏、肝脏和肾功能良好,生活状况良好。我们描述了供心获取、心肌保护、手术操作、免疫监测、抗排斥和抗感染治疗。我们介绍了在运送供心途中通过中度低温氧合血逆行灌注联合圣托马斯心脏停搏液保护供心的过程。除了心内膜活检,其他非侵入性检查如无创心输出量监测可能有助于监测急性排斥反应。